Risk Mismanagement: Where Pharma Companies Err

Overview:

In a survey of 65 life sciences execs, the Economist Intelligence Unit and KPMG found that risk management priorities are misguided. Companies fail to focus on embracing risk processes throughout their organizations, and most emphasize activities aimed at controlling regulatory risk rather than anticipating potentially greater threats.